Gray G, Collie S, Goga A, Garrett N, Champion J, Seocharan I, et al. Effectiveness of Ad26.COV2.S and BNT162b2 Vaccines against Omicron Variant in South Africa. N Engl J Med. 2022;386(23):2243-5. https://doi.org/10.1056/nejmc2202061
Effectiveness of Ad26.COV2.S and BNT162b2 Vaccines against Omicron Variant in South Africa.
By Peter Matlawa|2023-03-20T15:56:04+02:00March 20, 2023|2022: April to June|Comments Off on Effectiveness of Ad26.COV2.S and BNT162b2 Vaccines against Omicron Variant in South Africa.
Share This Story, Choose Your Platform!
About the Author: Peter Matlawa
Related Posts
Antimicrobial susceptibility and genomic profiling of Salmonella enterica from bloodstream infections at a tertiary referral hospital in Lusaka, Zambia, 2018-2019.